ARCHIVES

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

This article is from The Cancer Letter archive.

Vol. 07 No. 47 | November 20, 1981

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 4 Issue 1, Winter 1990

January 13, 1990

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

NCI To Require Reports On Adverse Drug Reactions From Trials

June 10, 1994

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

November 9, 1990

UPCI wins NCI SPORE grant for head and neck cancer.

September 24, 2004

First Mobil NMR Scanner Goes Into Operation At Temple

June 22, 1984